Tenon Medical, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Tenon Medical, Inc. announced its adjourned Annual Meeting will be held virtually on September 18, 2025, to vote on director elections, warrant exercisability, and an equity plan amendment.
NASDAQ
Tenon Medical, Inc. has announced its 2025 Annual Meeting of Stockholders, where key proposals include the election of directors, approval of new warrants from a recent inducement transaction, and a significant increase in the company's equity incentive plan share reserve.
NASDAQ
DEFR14A: Tenon Medical Amends Proxy Statement to Clarify Liquidation Preference of Series B Preferred Stock
Tenon Medical has amended its proxy statement to correct an error regarding the liquidation preference of its Series B Preferred Stock.
NASDAQ
DEFR14A: Tenon Medical Amends Proxy Statement to Clarify Liquidation Preference of Series B Preferred Stock
Tenon Medical has amended its proxy statement to correct an error regarding the liquidation preference of its Series B Preferred Stock.
NASDAQ
Tenon Medical is holding its 2024 Annual Meeting of Stockholders to vote on key proposals including the election of directors, approval of amendments to the equity incentive plan, and compliance with Nasdaq listing rules.